{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:42:10Z","timestamp":1761100930774,"version":"build-2065373602"},"reference-count":50,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":2656,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.bbmt.2007.10.002","type":"journal-article","created":{"date-parts":[[2007,12,28]],"date-time":"2007-12-28T10:51:49Z","timestamp":1198839109000},"page":"99-109","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Depletion of Alloreactive Donor T Lymphocytes by CD95-Mediated Activation-Induced Cell Death Retains Antileukemic, Antiviral, and Immunoregulatory T Cell Immunity"],"prefix":"10.1016","volume":"14","author":[{"given":"Udo F.","family":"Hartwig","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marion","family":"Nonn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shamsul","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irina","family":"Link","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Huber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Herr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2007.10.002_bib1","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1084\/jem.178.2.703","article-title":"Donor CD8 cells prevent allogeneic marrow graft rejection in mice: potential implications for marrow transplantation in humans","volume":"178","author":"Martin","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.bbmt.2007.10.002_bib2","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1126\/science.1352912","article-title":"Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T-cell clones","volume":"257","author":"Riddell","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.bbmt.2007.10.002_bib3","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1182\/blood.V76.12.2462.2462","article-title":"Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients","volume":"76","author":"Kolb","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.10.002_bib4","doi-asserted-by":"crossref","first-page":"806","DOI":"10.7326\/0003-4819-108-6-806","article-title":"Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion","volume":"108","author":"Goldman","year":"1988","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bbmt.2007.10.002_bib5","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1182\/blood.V75.3.555.555","article-title":"Graft-versus-leukemia reactions after bone marrow transplantation","volume":"75","author":"Horowitz","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.10.002_bib6","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1083-8791(99)70011-X","article-title":"Pathophysiologic mechanisms of acute graft-vs.-host disease","volume":"5","author":"Ferrara","year":"1999","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.10.002_bib7","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0301-472X(00)00677-9","article-title":"Acute graft-vs-host disease: pathobiology and management","volume":"29","author":"Goker","year":"2001","journal-title":"Exp Hematol"},{"key":"10.1016\/j.bbmt.2007.10.002_bib8","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1182\/blood.V86.4.1261.bloodjournal8641261","article-title":"Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease","volume":"86","author":"Mackinnon","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.10.002_bib9","doi-asserted-by":"crossref","first-page":"4207","DOI":"10.1182\/blood.V99.11.4207","article-title":"Donor-derived interferon gamma separates graft-versus-leukemia effects and graft-versus-host disease induced by donor CD8 T cells","volume":"99","author":"Yang","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.10.002_bib10","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S1040-8428(02)00108-7","article-title":"Immunotherapy of hematologic malignancies and metastatic solid tumors in experimental animals and man","volume":"46","author":"Slavin","year":"2003","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.bbmt.2007.10.002_bib11","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1182\/blood.V94.9.2999","article-title":"Allo-major histocompatibility complex-restricted cytotoxic T lymphocytes engraft in bone marrow transplant recipients without causing graft-versus-host disease","volume":"94","author":"Gao","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.10.002_bib12","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1046\/j.1365-2141.1996.d01-1713.x","article-title":"Graft-versus-leukaemia: understanding and using the alloimmune response to treat haematological malignancies","volume":"93","author":"Barrett","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2007.10.002_bib13","first-page":"517","article-title":"Distinct T cell populations distinguish chronic myeloid leukemia cells from lymphocytes in the same individual: a model for separating GVHD from GVL reactions","volume":"14","author":"Datta","year":"1994","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.10.002_bib14","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1073\/pnas.0337543100","article-title":"Definitive separation of graft-versus-leukemia- and graft-versus-host-specific CD4+ T cells by virtue of their receptor beta loci sequences","volume":"100","author":"Michalek","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bbmt.2007.10.002_bib15","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nrc1365","article-title":"Molecules and mechanisms of the graft-versus-leukemia effect","volume":"4","author":"Bleakley","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bbmt.2007.10.002_bib16","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1126\/science.276.5319.1719","article-title":"HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia","volume":"276","author":"Bonini","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.bbmt.2007.10.002_bib17","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1182\/blood.V99.9.3083","article-title":"Prevention of graft-versus-host disease while preserving graft-versus-leukemia effect after selective depletion of host-reactive T-cells by photodynamic cell purging process","volume":"99","author":"Chen","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.10.002_bib18","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1056\/NEJM199906033402202","article-title":"Transplantation of anergic histoincompatible bone marrow allografts","volume":"340","author":"Guinan","year":"1999","journal-title":"N Engl J\u00a0Med"},{"key":"10.1016\/j.bbmt.2007.10.002_bib19","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1182\/blood-2004-05-1918","article-title":"Functional assessment and specific depletion of alloreactive human T cells using flow cytometry","volume":"104","author":"Martins","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.10.002_bib20","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1046\/j.1365-2141.1998.00748.x","article-title":"Selective depletion of alloreactive T cells in HLA identical siblings: a method for separating graft-versus-host and graft-versus-leukemia reactions","volume":"101","author":"Mavroudis","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2007.10.002_bib21","doi-asserted-by":"crossref","first-page":"3550","DOI":"10.1182\/blood.V93.10.3550.410k24_3550_3557","article-title":"Depletion of alloreactive T cells by a specific anti-interleukin-2 receptor p55 chain immunotoxin does not impair in vitro antileukemia and antiviral activity","volume":"93","author":"Montagna","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.10.002_bib22","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1182\/blood-2002-11-3516","article-title":"Selective depletion of donor alloreactive T-cells without loss of antiviral or antileukemic responses","volume":"102","author":"Amrolia","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.10.002_bib23","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/sj.bmt.1701749","article-title":"Selective removal of alloreactive cells from haematopoietic stem cell grafts: graft engineering for GVHD prophylaxis","volume":"23","author":"Koh","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.10.002_bib24","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1046\/j.1365-2141.2000.02074.x","article-title":"Efficient depletion of alloreactive donor T lymphocytes based on expression of two activation-induced antigens (CD25 and CD69)","volume":"109","author":"Fehse","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2007.10.002_bib25","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1046\/j.1365-2141.1999.01675.x","article-title":"Selective depletion of major and minor histocompatibility antigen reactive T cells: towards prevention of acute graft-versus-host disease","volume":"107","author":"van Dijk","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2007.10.002_bib26","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1182\/blood-2006-04-014100","article-title":"Targeting the activation-induced antigen CD137 can selectively deplete alloreactive T\u00a0cells from anti-leukemic and anti-tumor donor T-cell lines","volume":"109","author":"Wehler","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.10.002_bib27","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1182\/blood-2006-02-001909","article-title":"Adoptive immunotherapy with allodepleted donor T-cells improves immune reconstitution after haploidentical stem cell transplantation","volume":"108","author":"Amrolia","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.10.002_bib28","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0140-6736(02)09413-8","article-title":"Immune reconstitution without graft-versus-host disease after haemopoietic stem-cell transplantation: a phase 1\/2 study","volume":"360","author":"Andre-Schmutz","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.bbmt.2007.10.002_bib29","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1182\/blood-2005-01-0393","article-title":"Selective depletion of alloreactive donor lymphocytes: a novel method to reduce the severity of graft-versus-host disease in older patients undergoing matched sibling donor stem cell transplantation","volume":"106","author":"Solomon","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.10.002_bib30","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1084\/jem.20020399","article-title":"Donor-type CD4(+) CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation","volume":"196","author":"Hoffmann","year":"2002","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.bbmt.2007.10.002_bib31","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1182\/blood.V99.8.3041","article-title":"Murine acute graft-versus-host disease can be prevented by depletion of alloreactive T lymphocytes using activation-induced cell death","volume":"99","author":"Hartwig","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.10.002_bib32","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0022-1759(01)00499-9","article-title":"The use of HLA-A\u22170201-transfected K562 as standard antigen-presenting cells for CD8(+) T lymphocytes in IFN-gamma ELISPOT assays","volume":"259","author":"Britten","year":"2002","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.bbmt.2007.10.002_bib33","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1172\/JCI119822","article-title":"CD40-activated human B cells: an alternative source of highly efficient antigen presenting cells to generate autologious antigen-specific T cells for adoptive immunotherapy","volume":"100","author":"Schultze","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bbmt.2007.10.002_bib34","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0022-1759(96)00078-6","article-title":"Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability","volume":"196","author":"Romani","year":"1996","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.bbmt.2007.10.002_bib35","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1084\/jem.181.1.71","article-title":"Fas ligand mediates activation induced cell death in human T lymphocytes","volume":"181","author":"Alderson","year":"1995","journal-title":"J Exp Med"},{"key":"10.1016\/j.bbmt.2007.10.002_bib36","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/sj.bmt.1705238","article-title":"Depletion of alloreactive T cells via CD69: implications on antiviral, antileukemic and immunoregulatory T lymphocytes","volume":"37","author":"Hartwig","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.10.002_bib37","doi-asserted-by":"crossref","first-page":"3950","DOI":"10.4049\/jimmunol.164.8.3950","article-title":"Cutting edge: increased expression of Bcl-2 in antigen-specific memory CD8+ T cells","volume":"164","author":"Grayson","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.bbmt.2007.10.002_bib38","first-page":"4296","article-title":"Natural T-cell immunity against cancer","volume":"9","author":"Nagorsen","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bbmt.2007.10.002_bib39","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1182\/blood.V95.7.2198","article-title":"Selective elimination of leukemic CD34(+) progenitor cells by cytotoxic T lymphocytes specific for WT1","volume":"95","author":"Gao","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.10.002_bib40","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.bbmt.2003.12.001","article-title":"Antiviral immunity and T-regulatory cell function are retained after selective alloreactive T-cell depletion in both the HLA-identical and HLA-mismatched settings","volume":"10","author":"Davies","year":"2004","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.10.002_bib41","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.4049\/jimmunol.149.5.1788","article-title":"Tissue distribution of human minor histocompatibility antigens. Ubiquitous versus restricted tissue distribution indicates heterogeneity among human cytotoxic T lymphocyte-defined non-MHC antigens","volume":"149","author":"de Bueger","year":"1992","journal-title":"J Immunol"},{"key":"10.1016\/j.bbmt.2007.10.002_bib42","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/(SICI)1099-1654(199709)7:3<181::AID-RMV200>3.0.CO;2-W","article-title":"T-cell therapy of human CMV and EBV infection in immunocompromised hosts","volume":"7","author":"Riddell","year":"1997","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.bbmt.2007.10.002_bib43","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1182\/blood-2003-02-0342","article-title":"Graft-versus-leukemia reactions in allogeneic chimeras","volume":"103","author":"Kolb","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.10.002_bib44","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.4049\/jimmunol.167.3.1245","article-title":"CD4+ CD25high regulatory cells in human peripheral blood","volume":"167","author":"Baecher-Allan","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.bbmt.2007.10.002_bib45","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","article-title":"Immunological self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25): breakdown of a single mechanism of self-tolerance causes various autoimmune diseases","volume":"155","author":"Sakaguchi","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.bbmt.2007.10.002_bib46","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1126\/science.1079490","article-title":"Control of regulatory T cell development by the transcription factor FOXP3","volume":"299","author":"Hori","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.bbmt.2007.10.002_bib47","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.0105-2896.2006.00426.x","article-title":"The role of the transcription factor Foxp3 in the development of regulatory T cells","volume":"212","author":"Kim","year":"2006","journal-title":"Immunol Rev"},{"key":"10.1016\/j.bbmt.2007.10.002_bib48","doi-asserted-by":"crossref","first-page":"750","DOI":"10.4049\/jimmunol.169.2.750","article-title":"Modulation of fas-dependent apoptosis: a dynamic process controlling both the persistence and death of CD4 regulatory T cells and effector T cells","volume":"169","author":"Banz","year":"2002","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.bbmt.2007.10.002_bib49","doi-asserted-by":"crossref","first-page":"32","DOI":"10.4049\/jimmunol.175.1.32","article-title":"In contrast to effector T cells, CD4+CD25+FoxP3+ regulatory T cells are highly susceptible to CD95 ligand- but not to TCR-mediated cell death","volume":"175","author":"Fritzsching","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.bbmt.2007.10.002_bib50","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nri2138","article-title":"Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans","volume":"7","author":"Roncarolo","year":"2007","journal-title":"Nat Rev Immunol"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879107005058?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879107005058?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:31:27Z","timestamp":1761057087000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879107005058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S1083879107005058"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2007.10.002","relation":{},"ISSN":["1083-8791"],"issn-type":[{"type":"print","value":"1083-8791"}],"subject":[],"published":{"date-parts":[[2008,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Depletion of Alloreactive Donor T Lymphocytes by CD95-Mediated Activation-Induced Cell Death Retains Antileukemic, Antiviral, and Immunoregulatory T Cell Immunity","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2007.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}